NCT07009210

Brief Summary

The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Aug 2025Jun 2027

First Submitted

Initial submission to the registry

May 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 6, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 11, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

1.3 years

First QC Date

May 29, 2025

Last Update Submit

September 10, 2025

Conditions

Keywords

Legacy Work

Outcome Measures

Primary Outcomes (2)

  • Feasibility Number

    Study feasibility will be measured by the number of participants who enrolled and finished the study.

    2 years

  • Acceptability

    Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items.

    5-10 days post-delivery of the final legacy document

Study Arms (1)

AI Assisted Personalized Legacy Program

EXPERIMENTAL
Behavioral: AI Assisted Personalized Legacy Program

Interventions

AI Assisted Personalized Legacy Program will be facilitated by a clinician trained in legacy work.

AI Assisted Personalized Legacy Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • English fluency
  • Provide informed consent
  • Ability to complete questionnaire(s) by themselves or with assistance

You may not qualify if:

  • Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
  • Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months
  • Active delirium
  • Advanced dementia
  • Participation in concurrent legacy offerings through the palliative care clinic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mayo Clinic

Phoenix, Arizona, 85054, United States

RECRUITING

Mayo Clinic

Rochester, Minnesota, 55905, United States

RECRUITING

Related Links

Study Officials

  • Deirdre Pachman, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 29, 2025

First Posted

June 6, 2025

Study Start

August 11, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

June 1, 2027

Last Updated

September 16, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations